Neoadjuvant pembrolizumab achieved a 71% pCR rate in desmoplastic melanoma, surpassing expectations for neoadjuvant anti–PD-1 treatment. The 3-year relapse-free survival rate was 74%, and the overall ...
The approach uses an iteration of the SHERLOCK technology exclusively licensed to OraSure Technologies' subsidiary, Sherlock Biosciences.
Polymerase Chain Reaction Market To Reach US$31.3Bn By 2033 Persistence Market Research. EINPresswire/ -- The global polymerase chain reaction (PCR) market, integral to molecular diagnostics and life ...
Background Tuberculous pleurisy (TBP) is a leading aetiology of exudative pleural effusion in tuberculosis (TB)-endemic regions and poses significant diagnostic challenges due to its paucibacillary ...
Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, announced the launch of the RNA Module for Countable PCR. This new solution brings ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Next-generation diagnostics is expected to use the abundant data on living bodies and ...
Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. In this work, we combined AuNRs with primers in the classic ...
In the race to detect disease earlier and more accurately, ultrasensitive molecular amplification technologies are emerging as a game-changer. At the heart of modern molecular diagnostics, these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results